AssetMark Inc’s Transmedics TMDX Stock Holding History

AssetMark Inc’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$918	Hold	11	–	–	﹤0.01%	3252
2026 Q2	$731	Sell	11 -8	-42%	-$677	﹤0.01%	3214
2026 Q1	$1.89K	Hold	19	–	–	﹤0.01%	2874
2025 Q4	$2.31K	Buy	19 +6	+46%	+$753	﹤0.01%	2739
2025 Q3	$1.46K	Buy	13 +9	+225%	+$1.05K	﹤0.01%	2699
2025 Q2	$536	Hold	4	–	–	﹤0.01%	2731
2025 Q1	$269	Sell	4 -6	-60%	-$413	﹤0.01%	2500
2024 Q4	$624	Hold	10	–	–	﹤0.01%	2335
2024 Q3	$1.57K	Hold	10	–	–	﹤0.01%	1922
2024 Q2	$1.51K	Buy	+10	New	+$1.2K	﹤0.01%	1792

Other funds holding TMDX

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.16B AUM 42.56% 1-Year Est. Return

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

Brown Capital Management Baltimore, Maryland $527M AUM 33.67% 1-Year Est. Return

Taylor Frigon Capital Management Scottsdale, Arizona $197M AUM 35.01% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Perigon Wealth Management San Francisco, California $6.5B AUM 20.72% 1-Year Est. Return

Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return

AssetMark Inc's TMDX Position: Q3 2026 in Review

AssetMark Inc held its Transmedics (TMDX) position steady in Q3 2026 at 11 shares worth $918. The position accounts for ﹤0.01% of the portfolio, ranked #3252.

AssetMark Inc first reported a position in TMDX in Q2 2024 and has held it in 10 quarters since. The position peaked at $2.31K in Q4 2025. 107 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

AssetMark Inc held 11 shares of Transmedics worth $918 as of Q3 2026.
AssetMark Inc left its Transmedics share count unchanged in Q3 2026.
Transmedics made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #3252 holding.
AssetMark Inc first reported a position in Transmedics in Q2 2024 and has held it in 10 quarters since.
AssetMark Inc's Transmedics position peaked at $2.31K in Q4 2025.
107 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.